To take a further step, our study investigated a pharmacological interruption of p-eIF2α/ATF4/Ihh in the IDD by employing the human NP cells in vitro and the mouse model in vivo. The gene discussed is EIF2A; the disease is intervertebral disk degenerative disorder.